TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2277567

Group type: EXPERIMENTAL
Intervention: 2 mL 1% lidocaine solution injected through the catheter on the tube.
Number of subjects: 30

Group type: COMPARATOR
Intervention: 2 mL 2% lidocaine solution injected through the catheter on the tube.
Number of subjects: 30
Study: 6993112

Group type: EXPERIMENTAL
Intervention: Ornidazole
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 31371228

Group type: EXPERIMENTAL
Intervention: Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) followed by routine adjuvant systemic chemotherapy
Number of subjects: 204

Group type: COMPARATOR
Intervention: Adjuvant systemic chemotherapy alone
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Adjuvant HIPEC
Number of subjects: 204
Study: 27583685

Group type: EXPERIMENTAL
Intervention: Chlorhexidine 0.25% antiseptic wipes
Number of subjects: 218

Group type: COMPARATOR
Intervention: Control group (no chlorhexidine)
Number of subjects: 218
Study: 26504148

Group type: EXPERIMENTAL
Intervention: Aspirin (81 mg/day for 14 days)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 156
Study: 24922355

Group type: EXPERIMENTAL
Intervention: EUS and CT (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: EUS only (group B)
Number of subjects: 72
Study: 22459542

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 21123503

Group type: EXPERIMENTAL
Intervention: Augmented kinematic feedback (F, M, FM)
Number of subjects: 32

Group type: COMPARATOR
Intervention: KR‐only (control)
Number of subjects: 32
Study: 17909381

Group type: EXPERIMENTAL
Intervention: Quality improvement interventions aimed at medical care providers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of automated records for trial design
Number of subjects: 0
Study: 15759538

Group type: EXPERIMENTAL
Intervention: Berg Balance Scale
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Rivermead Mobility Index
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Barthel Activities of Daily Living Index
Number of subjects: 47
Study: 11983043

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (0.15 mg/kg in 3 ml saline)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Saline (3 ml)
Number of subjects: 20
Study: 9858980

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Occlusive cuffs
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8572653

Group type: EXPERIMENTAL
Intervention: Propionibacterium avidum KP‐40
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propionibacterium granulosum KP‐45
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non Propionibacterium avidum KP‐40 treated)
Number of subjects: 0
Study: 2539186

Group type: EXPERIMENTAL
Intervention: Fluconazole (150 mg single oral dose)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Clotrimazole (200 mg intravaginal daily for 3 days)
Number of subjects: 369
Study: 7027234

Group type: EXPERIMENTAL
Intervention: Special risk factor intervention program directed at the reduction of elevated serum cholesterol, elevated diastolic blood pressure, and cigarette smoking
Number of subjects: 12000

Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 12000
Study: 31732552

Group type: EXPERIMENTAL
Intervention: Exercise group (EG) participated in a 3-month exercise program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CG) received no intervention
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 31015099

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Panic-Focused Psychodynamic Psychotherapy (PFPP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both CBT and PFPP
Number of subjects: 120
Study: 27927588

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10; 1,200mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10; 600mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 25925701

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000 (Monofer®)
Number of subjects: 351

Group type: COMPARATOR
Intervention: Iron sucrose (Venofer®)
Number of subjects: 351
Study: 23377324

Group type: EXPERIMENTAL
Intervention: Monopolar radiofrequency system (Pellevé S5 Wrinkle Treatment Generator)
Number of subjects: 31
Study: 21834655

Group type: EXPERIMENTAL
Intervention: Tailored footwear programme (player education, prescription of footwear, frequent rotation of footwear)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Tailored footwear programme
Number of subjects: 59
Study: 19397073

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study: 20057896

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (specific dosage and duration not mentioned)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15688690

Group type: EXPERIMENTAL
Intervention: Dan Zhi Xiao Yao Yin combined with auricular-point-pressing therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Routine western drugs
Number of subjects: 51
Study: 12182776

Group type: EXPERIMENTAL
Intervention: Insulated four-contact array (laminectomy)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Permanent percutaneous electrode
Number of subjects: 24

Group type: COMPARATOR
Intervention: Temporary percutaneous electrode
Number of subjects: 24
Study: 9006703

Group type: EXPERIMENTAL
Intervention: Temperature at 65 degrees C
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Temperature at 70 degrees C
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Temperature at 75 degrees C
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Temperature at 80 degrees C
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Temperature at 65 degrees C, 70 degrees C, 75 degrees C, and 80 degrees C
Number of subjects: 6

Group type: COMPARATOR
Intervention: Temperature at 37 degrees C
Number of subjects: 6
Study: 8214995

Group type: EXPERIMENTAL
Intervention: CMVIG
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo (1% albumin)
Number of subjects: 141
Study: 3565119

Group type: EXPERIMENTAL
Intervention: Floating environment intervention; duration not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control subjects; procedures used on them not specified.
Number of subjects: 0
Study: 11600543

Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Holding the infant
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43
Study: 30984980

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 70

Group type: COMPARATOR
Intervention: LASIK
Number of subjects: 70
Study: 30348137

Group type: EXPERIMENTAL
Intervention: Peer support intervention (group-based program delivered by trained peer volunteers over 12 months)
Number of subjects: 0
Study: 25946038

Group type: EXPERIMENTAL
Intervention: 50% of V ˙ O 2 m a x training intensity
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 70% of V ˙ O 2 m a x training intensity
Number of subjects: 12
Study: 24887611

Group type: EXPERIMENTAL
Intervention: Color-selective attention task (Attend vs Ignore)
Number of subjects: 38
Study: 23167405

Group type: EXPERIMENTAL
Intervention: Surgery plus 1-week continuous infusion of 5-FU (1000 mg/d) and heparin (5000 IU/d) infusion initiated from the day of surgery for 7 consecutive days (study group)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Surgery alone (observational group)
Number of subjects: 64
Study: 20479295

Group type: EXPERIMENTAL
Intervention: Appearance-focused intervention including a booklet discussing tanning history, UV radiation effects, and healthier alternatives.
Number of subjects: 430

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 430
Study: 18661551

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) just before surgery
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (not being considered for DBS)
Number of subjects: 3
Study: 15644155

Group type: EXPERIMENTAL
Intervention: Xincang Decoction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketotifen fumarate
Number of subjects: 60
Study: 11823651

Group type: EXPERIMENTAL
Intervention: Stroke unit care for large-vessel infarcts
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Stroke unit care for lacunar strokes
Number of subjects: 267

Group type: COMPARATOR
Intervention: Stroke team care for large-vessel infarcts
Number of subjects: 267

Group type: COMPARATOR
Intervention: Stroke team care for lacunar strokes
Number of subjects: 267
Study: 10730517

Group type: EXPERIMENTAL
Intervention: Bifidobacterium Bb12 supplemented milk-based formula
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Bifidobacterium Bb12 and Streptococcus thermophilus supplemented milk-based formula
Number of subjects: 175

Group type: COMPARATOR
Intervention: Milk-based follow-up formula (Control)
Number of subjects: 175
Study: 7670454

Group type: EXPERIMENTAL
Intervention: 7% carbohydrate‐electrolyte (CE) drink
Number of subjects: 8

Group type: COMPARATOR
Intervention: Flavored water placebo (PL)
Number of subjects: 8
Study: 1844536

Group type: EXPERIMENTAL
Intervention: Quinine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinine/Clindamycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 0

Group type: COMPARATOR
Intervention: 4-aminoquinolines and sulfadoxine-pyrimethamine
Number of subjects: 0
Study: 7283808

Group type: EXPERIMENTAL
Intervention: 0.25% dipivefrin twice a day plus 0.25% echothiophate iodide twice a day
Number of subjects: 8

Group type: COMPARATOR
Intervention: 2% epinephrine hydrochloride twice a day plus 0.25% echothiophate iodide twice a day
Number of subjects: 8
Study: 31159569

Group type: EXPERIMENTAL
Intervention: Correction Kinesiotaping
Number of subjects: 7

Group type: COMPARATOR
Intervention: Sham Kinesiotaping
Number of subjects: 7
Study: 28012168

Group type: EXPERIMENTAL
Intervention: Permanent housing subsidies that reduce expenditures for rent to 30% of families' income
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Temporary rapid re‐housing subsidies with some services directed at housing and employment
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Transitional housing in supervised facilities with extensive psychosocial services
Number of subjects: 1857

Group type: COMPARATOR
Intervention: Usual care families (control group)
Number of subjects: 1857
Study: 24755722

Group type: EXPERIMENTAL
Intervention: Methohexital
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 20
Study: 23728931

Group type: EXPERIMENTAL
Intervention: Specialist diet and exercise advice tailored to individual family circumstances
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Involvement of children in the decision to attend a clinic
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Clinic environment
Number of subjects: 32
Study: 22264722

Group type: EXPERIMENTAL
Intervention: Valsartan (V; 160 then 320 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Carvedilol (C; 20 then 40 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lisinopril (L; 40 mg/day)
Number of subjects: 30
Study: 19066176

Group type: COMPARATOR
Intervention: Placebo plus methotrexate
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg plus placebo
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Golimumab 50 mg plus methotrexate
Number of subjects: 444

Group type: EXPERIMENTAL
Intervention: Golimumab 100 mg plus methotrexate
Number of subjects: 444
Study: 17878518

Group type: EXPERIMENTAL
Intervention: 70-gene signature (Mammaprint®™) for selecting patients for adjuvant chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional clinicopathological criteria for adjuvant chemotherapy
Number of subjects: 0
Study: 16279899

Group type: EXPERIMENTAL
Intervention: Peg-IFN-alpha2b + RBV for 24 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Peg-IFN-alpha2b + RBV for 48 weeks (Control)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Induction-dose triple therapy (IDTT) with IFN-alpha2b + RBV + AMD for 24 weeks
Number of subjects: 180
Study: 11329797

Group type: EXPERIMENTAL
Intervention: Antibacterial therapy
Number of subjects: 0
Study: 9707202

Group type: EXPERIMENTAL
Intervention: Teaching intervention for nurses on positioning stroke patients
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no teaching intervention)
Number of subjects: 38
Study: 9071414

Group type: EXPERIMENTAL
Intervention: Carbon dioxide laser and adjuvant systemic interferon alpha-2b
Number of subjects: 100

Group type: COMPARATOR
Intervention: Carbon dioxide laser and placebo
Number of subjects: 100
Study: 2448561

Group type: EXPERIMENTAL
Intervention: Haemodilution (by venesection and replacement of the same volume of dextran 40 in saline solution)
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Haemodilution
Number of subjects: 1267
Study: 31713952

Group type: EXPERIMENTAL
Intervention: Cogmed working memory training (45-min sessions, 5 days a week over 5-7 weeks)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo program (45-min sessions, 5 days a week over 5-7 weeks)
Number of subjects: 91
Study: 31397263

Group type: EXPERIMENTAL
Intervention: 4AT (n = 392)
Number of subjects: 785

Group type: COMPARATOR
Intervention: CAM (n = 382)
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: 4AT positive scores
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Initial inpatient stay for patients with delirium
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: False-positive cases
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: False-negative cases
Number of subjects: 785

Group type: EXPERIMENTAL
Intervention: Missed diagnosis
Number of subjects: 785
Study: 28146219

Group type: EXPERIMENTAL
Intervention: ABBM-PRF combination
Number of subjects: 15

Group type: COMPARATOR
Intervention: ABBM alone (control group)
Number of subjects: 15
Study: 26788875

Group type: EXPERIMENTAL
Intervention: Santes® (two suppositories per day for 4 months, first two months simultaneous to RT and BRT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no treatment during RT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Santes® (two suppositories per day for 4 months)
Number of subjects: 45
Study: 23167574

Group type: EXPERIMENTAL
Intervention: Warm showers (20 minutes duration, water temperature maintained at 37°C)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard childbirth care (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Warm showers
Number of subjects: 80
Study: 21808190

Group type: EXPERIMENTAL
Intervention: Oral micronized progesterone (100 mg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Triazolam (0.06, 0.12 and 0.25 mg/70 kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combination of progesterone and triazolam
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Progesterone alone
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 19537955

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 412
Study: 16641126

Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg chewable tablets administered once daily in the evening)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 15613121

Group type: EXPERIMENTAL
Intervention: Structured weekly educational telephone intervention (8 weeks)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 168
Study: 11004060

Group type: EXPERIMENTAL
Intervention: Aggressive warming (maintaining tympanic membrane temperature of 36.5 degrees C)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional warming (maintaining temperature of 36 degrees C)
Number of subjects: 150
Study: 8639197

Group type: EXPERIMENTAL
Intervention: Prochlorperazine (10 mg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Metoclopramide (10 mg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (sterile saline)
Number of subjects: 86
Study: 1317272

Group type: EXPERIMENTAL
Intervention: Atropine (1.2 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (dextrose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12
Study: 6140906

Group type: EXPERIMENTAL
Intervention: Ipecac (30 mL, repeated if vomiting not induced)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Activated charcoal (60 g) with magnesium sulfate (MgSO4)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ipecac followed by activated charcoal/MgSO4 (given 1 1/2 hours after last vomiting episode)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (aspirin only)
Number of subjects: 12
Study: 31793541

Group type: EXPERIMENTAL
Intervention: Sustagard Artro (1 sachet once a day for 6 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAIDs (injectable forms for 3-7 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sustagard Artro (CP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 60
Study: 28664576

Group type: EXPERIMENTAL
Intervention: Vasodilator stress with dipyridamole
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Modest plantar flexion exercise (20 watts)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Surgical revascularization followed by exercise
Number of subjects: 18
Study: 26553615

Group type: EXPERIMENTAL
Intervention: 1 mg/mL histamine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 6 mg/mL histamine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All devices tested
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multi-Test PC and UniTest PC
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Multiheaded vs single-head devices
Number of subjects: 24
Study: 23639228

Group type: EXPERIMENTAL
Intervention: Pidotimod (800 mg single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Limited Sampling Strategy (LSS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Two formulations of pidotimod
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: LSS method for assessing bioequivalence
Number of subjects: 0
Study: 20858104

Group type: EXPERIMENTAL
Intervention: Conventional RT plus intracavity hyperthermia (T90 42.5°‐43°C for 50 min twice a week for 7 weeks)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Conventional RT alone
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Conventional RT plus intracavity hyperthermia
Number of subjects: 180
Study: 19463505

Group type: EXPERIMENTAL
Intervention: Heart rate turbulence (HRT) using 24-hour Holter monitoring
Number of subjects: 481
Study: 17725476

Group type: EXPERIMENTAL
Intervention: Voluntary pelvic floor muscle contraction in standing
Number of subjects: 65

Group type: COMPARATOR
Intervention: Voluntary pelvic floor muscle contraction in crook‐lying
Number of subjects: 65
Study: 15113612

Group type: EXPERIMENTAL
Intervention: Fixed dose combination (FDC) tablet of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard separate combination of rifampicin, isoniazid, and pyrazinamide
Number of subjects: 22
Study: 12407136

Group type: EXPERIMENTAL
Intervention: Artesunate (4 mg/kg/day for 3 days)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 10037133

Group type: EXPERIMENTAL
Intervention: Automated specific treponemal test (PK‐TP)
Number of subjects: 4878215

Group type: COMPARATOR
Intervention: Rapid plasma reagin test (RPR)
Number of subjects: 4878215

Group type: EXPERIMENTAL
Intervention: PK‐TP test
Number of subjects: 4878215

Group type: EXPERIMENTAL
Intervention: Serologic testing for syphilis
Number of subjects: 4878215
Study: 7548288

Group type: EXPERIMENTAL
Intervention: 0.5% podophyllotoxin cream (Condyline), applied twice daily for three days in weekly intervals
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20% podophyllin solution, applied weekly
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.5% podophyllotoxin cream (Condyline)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 20% podophyllin solution
Number of subjects: 60
Study: 1657111

Group type: EXPERIMENTAL
Intervention: Continuous, Hyperfractionated, Accelerated Radiotherapy (CHART)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of chemotherapy and radiotherapy
Number of subjects: 0
Study: 7033559

Group type: EXPERIMENTAL
Intervention: Streptotriad
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bismutum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethacridine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fultrexine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sulphadoxine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Difenoxine
Number of subjects: 0
Study: 6376719

Group type: EXPERIMENTAL
Intervention: MTX followed one hour later by 5‐FU
Number of subjects: 108

Group type: COMPARATOR
Intervention: 5‐FU followed one hour later by MTX
Number of subjects: 108
Study: 29507942

Group type: EXPERIMENTAL
Intervention: IV methylprednisolone sodium succinate (1000-mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Oral prednisone (1250-mg)
Number of subjects: 55
Study: 27430605

Group type: EXPERIMENTAL
Intervention: Preventive intercostal nerve block (ICNB) followed by catheter-based infusion of 0.5% bupivacaine
Number of subjects: 66

Group type: COMPARATOR
Intervention: Intravenous (IV) analgesia alone
Number of subjects: 66
Study: 24913161

Group type: EXPERIMENTAL
Intervention: Voriconazole (6 mg/kg IV q12h for 24h followed by 4 mg/kg IV q12h, switched to 300 mg orally q12h as appropriate)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Anidulafungin (200 mg loading dose followed by 100 mg IV q24h)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Voriconazole
Number of subjects: 305
Study: 23730580

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray and nasal breathing exercise (NBE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluticasone propionate nasal spray
Number of subjects: 60
Study: 20547444

Group type: EXPERIMENTAL
Intervention: Betamethasone (2x12 mg within 24 h)
Number of subjects: 8